Constellium is trading at $23.45, down 4.52%, with no reliable report identifying a specific downside catalyst. - Reported record third-quarter adjusted EBITDA of $276 million. - Raised 2026 adjusted EBITDA guidance to $1.03–$1.06 billion; the earnings release was positive. - Shares were up 4.40% in pre-market trading after the announcement; trading volume information was unavailable.